Quick Answer
ImageneBio, Inc. reported Common Stock Shares Outstanding of 48.26 million shares for the year ending 2024.
- ImageneBio, Inc. showed an increase of +0.0% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from ImageneBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: 35.85 million shares | Q2 2021: 35.86 million shares | Q3 2021: 35.88 million shares | Q1 2022: 36.11 million shares | Q2 2022: 36.25 million shares | Q3 2022: 36.26 million shares | Q1 2023: 36.26 million shares | Q2 2023: 42.30 million shares | Q3 2023: 44.10 million shares | Q1 2024: 48.26 million shares | Q2 2024: 48.26 million shares | Q3 2024: 48.26 million shares | Q4 2024: 48.26 million shares | Q1 2025: 48.26 million shares | Q2 2025: 48.26 million shares.
- Over the full 5 years of available data (2020 to 2024), ImageneBio, Inc.'s Common Stock Shares Outstanding has grown by 1,458.3%.
- Historical annual values: Fiscal year 2024: 48.26 million shares | Fiscal year 2023: 48.26 million shares | Fiscal year 2022: 36.26 million shares | Fiscal year 2021: 35.98 million shares | Fiscal year 2020: 3.10 million shares.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: